Celltrion
068270.KS
#819
Rank
S$38.22 B
Marketcap
S$167.61
Share price
-0.67%
Change (1 day)
1.79%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): S$4.20

According to Celltrion 's latest financial reports the company's current EPS (TTM) is S$4.16. In 2025 the company made an earnings per share (EPS) of S$3.95 an increase over its 2024 EPS that were of S$1.50.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.206.31%
2025S$3.95163.66%
2024S$1.50-53.73%
2023S$3.24-2.08%
2022S$3.30-11.72%
2021S$3.742.03%
2020S$3.6782.8%
2019S$2.0118.31%
2018S$1.70-36.33%
2017S$2.66161.25%
2016S$1.022.86%
2015S$0.9917.84%
2014S$0.845.87%
2013S$0.79-70.85%
2012S$2.73134.09%
2011S$1.1643.59%
2010S$0.8174.49%
2009S$0.46317.8%
2008S$0.11-71.7%
2007S$0.39